Preclinical validation of human recombinant glutamate-oxaloacetate transaminase for the treatment of acute ischemic stroke

Authors
Mara Prez-Mato, Antonio Dopico-Lpez, Yunus Akkoc, Sonia Lpez-Amoedo, Clara Correa-Paz, Mara Candamo-Lourido, Ramn Iglesias-Rey, Esteban Lpez-Arias, Ana Bugallo-Casal, Andrs da Silva-Candal, Susana B. Bravo, Mara del Pilar Chantada-Vzquez, Susana Arias, Mara Santamara-Cadavid, Ana Estany-Gestal, Ahlem Zaghmi, Marc A. Gauthier, Mara Gutirrez-Fernndez, Abraham Martin, Jordi Llop, Cristina Rodrguez, ngeles Almeida, Martina Migliavacca, Ester Polo, Beatriz Pelaz, Devrim Gozuacik, Naouale El Yamani, Tanima SenGupta, Elise Rundn-Pran, Jos Vivancos, Mar Castellanos, Exuperio Dez-Tejedor, Toms Sobrino, Aharon Rabinkov, David Mirelman, Jos Castillo, Francisco Campos


Lab

Journal
iScience

Abstract

Summary

The blood enzyme glutamate-oxaloacetate transaminase (GOT) has been postulated as an effective therapeutic to protect the brain during stroke. To demonstrate its potential clinical utility, a new human recombinant form of GOT (rGOT) was produced for medical use.

We tested the pharmacokinetics and evaluated the protective efficacy of rGOT in rodent and non-human primate models that reflected clinical stroke conditions.

We found that continuous intravenous administration of rGOT within the first 8h after ischemic onset significantly reduced the infarct size in both severe (30%) and mild lesions (48%). Cerebrospinal fluid and proteomics analysis, in combination with positron emission tomography imaging, indicated that rGOT can reach the brain and induce cytoprotective autophagy and induce local protection by alleviating neuronal apoptosis.

Our results suggest that rGOT can be safely used immediately in patients suspected of having a stroke. This study requires further validation in clinical stroke populations.

Keywords/Topics
preclinical;validation;human;recombinant;glutamate-oxaloacetate;transaminase;treatment;acute;ischemic;stroke

BIOSEB Instruments Used:
Grip strength test (BIO-GS4)

Source :

https://www.cell.com/iscience/fulltext/S2589-0042(24)02333-2

Produits associés

Test d'agrippement

DEMANDE DE PUBLICATION

Merci de votre intérêt pour notre gamme de produits et de votre demande pour cette publication qui vous sera envoyée si l'équipe de recherche et la revue le permettent. Notre équipe commerciale vous contactera dans les plus brefs délais.